logo
Plus   Neg
Share
Email

3D Systems Profit Falls, But Tops Estimates; Provides Strong Outlook; Stock Up

3D Systems Corp. (DDD) Thursday reported a drop in fourth-quarter earnings as increased selling and other costs offset a 35 percent jump in revenue. But, excluding items, earnings rose from last year and topped analysts' estimates, as did revenue.

The Rock Hill, South Carolina-based maker of 3D printers and related products also provided a strong earnings outlook for the full year 2012, sending its shares up by 17 percent in morning trade on the New York Stock Exchange.

CEO Abe Reichental said that despite economic volatility and issues arising from its rapid expansion, the company is well placed to tap the opportunities in the manufacturing and emerging consumer markets.

During the fourth quarter 2011, all of the company's segments saw growth. Sales of 3D printer nearly tripled from last year, but accounted for only a slight rise in revenue due to the shift towards lower price products. Meanwhile, print materials segment rose 21 percent, and service also posted robust growth.

Net income for the quarter fell to $8 million or $0.16 per share from $9.4 million or $0.20 per share a year ago. Excluding items, adjusted earnings was $13.8 million or $0.27 per share, compared to $9.6 million or $0.20 per share last year.

On average, five analysts polled by Thomson Reuters expected earnings of $0.16 per share for the quarter. Analysts' estimates typically exclude special items.

The company's revenue grew to $70 million from $51.6 million last year. Analysts expected revenue of $63.66 million.

The company expects full year 2012 adjusted earnings of $1.00 to $1.25 per share and revenue of $330 million to $360 million. Analysts currently expect earnings of $0.80 per share and revenue of $291.87 million for the full year 2012.

Last month, 3D Systems completed the acquisition of Z Corp. and Vidar Systems for $135.5 million from Contex Group, a subsidiary of Ratos AB, a private equity company located in Stockholm, Sweden. The deal is expected to be immediately accretive to the company's adjusted earnings in the first full year following closure.

DDD is trading at $24.59, up $3.66 or 17.49%, on the NYSE.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT